Physician profile
Cory Ryan
NPI 1467443879
$1,081.69
in general payments reported to CMS, 2019-2025
20 companies · $180 in 2025
The $180 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $109 · 2022: $136 · 2023: $256 · 2024: $216 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.84 | 2021-2025 | Vraylar, Ubrelvy |
| Lilly USA, LLC | $109.24 | 2020-2024 | Zepbound, Mounjaro |
| Indivior INC. | $93.56 | 2024-2025 | Sublocade |
| Glaxosmithkline, LLC. | $87.94 | 2020-2023 | Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $87.76 | 2022-2025 | Rexulti |
| Teva Pharmaceuticals USA, INC. | $73.95 | 2023 | Austedo |
| Allergan, INC. | $62.43 | 2020 | |
| Alkermes, INC. | $51.57 | 2020-2025 | Vivitrol |
| Braeburn INC. | $44.74 | 2024-2025 | Brixadi |
| Novartis Pharmaceuticals Corporation | $38.99 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.11 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $26.48 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.98 | 2024 | Caplyta |
| Medtronic, INC. | $20.73 | 2024 | Minimed 780g |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.56 | 2020 | |
| Soleno Therapeutics, INC. | $15.39 | 2025 | Vykat Xr |
| Vanda Pharmaceuticals INC. | $14.17 | 2025 | Fanapt |
| Avion Pharmaceuticals | $13.18 | 2022 | |
| Novo Nordisk INC | $13.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.